跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack
Approved
STANDARD
XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2351db5deb4f86c2
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
2351db5deb4f86c2
Product Name
XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack
Artg Id
150854
Artg Name
XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2008-03-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2351db5deb4f86c2
Type
Standard
Back to TGA Approvals
